 6. Has any screening abnormal laboratory value that suggests a clinically significant underlying disease or condition that may prevent the subject from entering the study; or the subject has: creatinine 1.5 milligram per deciliter mgdL, alanine aminotransferase ALT andor aspartate aminotransferase AST 2 times the upper limit of normal ULN, or total bilirubin 2.0 mgdL, with ASTALT elevated above the limits of normal values. 